Evidence map›Paper›PMID 42021794›Full record

ArticleMedical journal of the Islamic Republic of Iran2025

Efficacy of Sequential Metronidazole and Furazolidone with Proton Pump Inhibitors versus Standard Regimen in Treating

Mohammad Taher, Mahdieh Esfandiari, Hamid Abredari, Kouros Aghazade Sarhangipour, Leila Taheri, Leila Ghanbari-Afra, Mohammad Reza Rouhani

Abstract read
In one paragraph

Article in Medical journal of the Islamic Republic of Iran, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mohammad TaherFaculty of Nursing and Midwifery, Saveh University of Medical Sciences, Saveh, Iran.
Mahdieh EsfandiariDepartment of Internal Medicine, Arak University of Medical Sciences, Arak, Iran.
Hamid AbredariFaculty of Nursing and Midwifery, Saveh University of Medical Sciences, Saveh, Iran.
Kouros Aghazade SarhangipourInfectious Diseases Research Center, AJA University of Medical Sciences, Tehran, Iran.
Leila TaheriFaculty of Nursing and Midwifery, Qom University of Medical Sciences, Qom, Iran.
Leila Ghanbari-AfraFaculty of Nursing and Midwifery, Qom University of Medical Sciences, Qom, Iran.
Mohammad Reza RouhaniDepartment of Internal Medicine, Saveh University of Medical Sciences, Saveh, Iran.ORCID https://orcid.org/0000-0001-8035-2433

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: In this randomized, parallel-group clinical trial, 110 patients with confirmed Results: The eradication rate was significantly higher in the intervention group than in the control group (76.4% vs. 56.4%, χ² = 4.928, Conclusion: The 1-week sequential regimen demonstrated significantly higher eradication rates and better tolerability compared to the standard triple therapy. This approach may offer a more effective and safer option for treating

Indexed as

AntibioticsFurazolidoneHelicobacter PyloriMetronidazoleProton Pump Inhibitor (PPI)

Identifiers

PMID42021794
PMCPMC13097231

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.